Mumbai hosts largest ever CPhI India events cluster

19-Jan-2011

Record attendance reflects accelerated growth in Indian pharma market

Leading events organiser UBM Live has confirmed the largest ever attendance for its Indian tradeshows: CPhI India for pharmaceutical ingredients and intermediates; and co-located events, P-MEC for equipment and machinery; ICSE for contract services and packaging; and BioPh for the biopharma sector. The events took place from 1–3 December 2010 at the Bombay Exhibition Centre in Mumbai.

Visitor number increased to reach a total of 26,436, including 1,433 international visitors, while booths for the 800+ exhibitors sold out in record time and delivered exhibitors from 18 countries. With such high exhibitor levels, visitors were given a great platform for networking with companies that span all facets of the fine chemicals and pharmaceutical machinery industries.

The international attendance reflects the growing significance of India in the pharma industry globally, and India’s presence and importance is only expected to grow. A few of the highlights of the events included the Pharma Summit, which had more than 330 people in attendance.

Another big attraction this year for visitors was the CPhI India Conference Series 2010, which ran alongside the main events and drew in more than 322 visitors. The conferences were comprised of 12 modules covering the most relevant topics in the Indian marketplace, including: drug discovery, biosimilars, nanotechnology, vaccines, oncology, stem cells, generics, and machinery.

‘We anticipated a high turnout for the event this year, and we were not disappointed,’ said Annemieke Timmers, CPhI Brand Director. ‘We were especially pleased with the international presence at the show, it just goes to show that the global stage is recognising India as a major player in the machinery and fine chemical markets.

‘In the second annual CPhI India conference series we tried a new approach with a modular conference format. While this is a new concept to the India pharma market, it was very well received and we intend to continue with this system for the 2011 events.’

‘The introduction of the ICSE Pavilion provided a core focus on outsourcing and contract services – a sector that has seen 43% growth annually in India, three times the global rate. With a highly trained workforce, India is one of the most advantageous markets to grow business,’ noted Haf Cennydd, Event Director of ICSE/P-MEC/BioPh India. ‘India is also an increasingly important player in the contract services market including packaging, clinical trials, laboratory services, drug discovery and marketing services.’

In addition to the general expansion of the India pharma market, the associated machinery and equipment market is growing on average at 15-20% per year. Consequently P-MEC was a resounding success, seeing record attendance in 2010 with 10,446 visitors and 248 exhibitors. Initial feedback from exhibitors and attendees was uniformly positive with steady foot traffic and exhibitors reporting expanded business potential for India.

Sign up for your free email newsletter

The 2011 event will return to The Bombay Exhibition Centre in Mumbai from 30 November – 2 December 2011.

Companies